Prof. Ofer Nativ

Urological surgeon
Head of the urology department, “Bnei Zion” Medical Center

Departments: Urology

Overview:

Prof. Ofer Nativ is graduate of Faculta de Medicina e Chirurgia, Universita de Milano, Italy.
Obtained Special training in Urology Surgery in several leading hospitals around the world. Specializes in complex bladder, prostate and kidney cancer.

Education and Academic Degrees:

Since 1999: Associated Professor, Technion Institute of Technology, Faculty of Medicine.
1994-1999: Senior lecturer, Technion Institute of Technology, Faculty of Medicine.
1992-1996: Senior lecturer, Tel-Aviv University, Sackler School of Medicine, Dept. of surgery, section of Urology.
1983-1992: Instructor, Tel-Aviv University, Sackler School of Medicine, Department of surgery, Section of Urology.

Professional Experience:

1973-1976: Medical studies: Faculta de Medicina e Chirurgia, Universita de Milano, Italy.
1976-1979: Medical studies: Tel-Aviv University, Sackler school of Medicine. MD Thesis: A review of patients with hypernephroma at Beilinson Hospital between
1968-1979: (supervisors – Prof. C. Servadio, Dr. E. Mukamel).
July, 1981: M.D. degree, Tel-Aviv University, Medical license no.-14836
1979-1980: Rotating internship, Hasharon Hospital, Petah-Tiqva.
1981-1982: Resident, Dept. Urology, Sheba Medical Center (Head of Dept., Prof. M. Manny)
1982-1984: Rotating residency, Dept. General Surgery & Transplantation, Sheba Medical Center, (Head of Dept., Prof. E.T. Jacob).
1984-1985: Experimental research, Dept. Cell Biology, Sackler School of Medicine. (Supervisor, Prof. M. Aronson).
1985-1986: Chief resident, Dept. Urology, Sheba Medical Center (Head of Dept., Prof. M. Manny).
1986-1987: Rotating residency, Dept Obstetrics & Gynecology, Sheba Medical Center. (Head of Dept., Prof. S. Mashiach).
Dec. 1987: Receipt of Specialization Certificate, no. 09588.
1981-1987: Tel-Aviv University, Sackler School of Medicine, Postgraduate Medical School, MSc in Urology.
1987-1989: Research fellow, Urology research laboratory, Mayo Clinic, Rochester, MN. (Supervisor, Prof. M.M. Lieber).
1987-1988: Course in Biostatistics. Rochester, MN, USA.
1988: Course in Endouroliogical Surgery. Minneapolis, MN, USA.
1989: Course in Prostate Ultrasound. Atlanta, GA, USA.
1989 : Course in Microvascular Surgical Techniques. Rochester, MN, USA
1989-1990: Clinical fellow, Urologic Service, Memorial Sloan-Kettering Cancer Center, New York, NY (Chief, Prof. W.R. Fair).
1990-1993: Senior Consultant, Dept. Urology, Sheba Medical Center. (Head of Dept. Prof. B. Goldwasser).
Since 1993: Head Dept. Urology, Bnai Zion Medical Center, Haifa.

Research Interests:

Experimental therapeutic agents for superficial bladder cancer.
Flow cytometeric nuclear DNA analysis of genitourinary malignancies.
Morphometric characterization of genitourinary neoplasms.
Development of surgical techniques and devices for the management of urinary incontinence.
Noninvasive detection of bladder cancer by means of proteomic and metabolomic analysis.
Improving drug delivery for treatment of superficial bladder cancer.
Assessment the role of tissue adhesives in nephron sparing surgery.
Functional preservation in nephron sparing surgical procedures.
Ischemic damage to the kidney during nephron sparing surgery.

Public Professional Activities:

1991-2011: Member of the committee for examinations in urology, Israel Medical Association, Scientific council.
Since 1991: Member of the national board of examiners in urology.
Since 1992: Expert reviewer for Urology.
Since 1993: Expert reviewer for International Journal of Cancer.
1994-2000: Member of the research committee, faculty of medicine, Technion.
Since 1995: Member of the specialization committee, Israel Medical Association, scientific council.
Since 1996: Expert reviewer for cancer.
1996-2000: Member of the executive committee of the Israeli Urological Association.
Since 1998: Expert reviewer for European Urology
Since 2000: Expert reviewer for IMAJ
Since 2000: Member of the Urologic-Oncology committee of the Israel Cancer Association.
Since 2004: Member of the editorial board of IMAJ.
Since 2000: Experts reviewer for the Journal of Urology
Since 2006: Expert reviewer Urologic Oncology.
Since 2005: Expert reviewer for grant application to the Israeli Ministry of health.
Since 2008: Member of cancer prevention committee, Israel Cancer Association.
Since 2010: Expert reviewer for Scandinavian Journal of Urology & Nephrology.
Since 2010: Member of the editorial board and reviewer WJUR.

Conferences and Invited Talks:

Nativ O.: Static Image Cytometry for Measurement of Nuclear DNA Content from Pre-Operative Prostate Needle Biopsy Specimens. AUA, New York, NY, 1990.
Nativ O.: Premalignant Lesions of the Bladder: Diagnosis and Treatment. SFU. Nantes, France, 1991.
Nativ O.: Nephron Sparing Surgery for Renal Cell Carcinoma. European School of Oncology, Jerusalem, Israel, 1997.
Nativ O.: New Surgical Techniques for the Management of Female Incontinence. ICS. Yokohama, Japan, 1997.
Nativ O.: Incisionless Transvaginal Bone Anchor Sling Procedure. Genoa, Italy, 1998.
Nativ O.: Bone Anchor Male Sling for Post Prostatectomy Incontinence, Hamburg, Germany, 1999.
Nativ O.: Co-Chairman Session on Basic Research for Urothelial Cancer, EAU, Paris, France, 2006.
Schulman C., Kirkaly Z., Nativ O.: EAU Panel on Case Management in Kidney Cancer. Eilat, Israel, 2007.
Nativ O.: The Advantages of Open Approach in Nephron Sparing Surgery. CURY , Barcelona, Spain, 2008.
Nativ O.: The Case for Conservative Approach in the Management of BCG Failure Patients. CURY, Barcelona, Spain, 2008.
Nativ O.: Update on Screeining and Early Detection of Prostate Cancer. Sanofi-Aventis Meeting, Kfar Blum, Israel, 2008.
Nativ O.: What is Left for Open Nephrectomy. CURY, Lisbon Portugal, 2009.
Nativ O.: The Advantages of Open Nephron Sparing Surgery. CURY, Lisbon Portugal, 2009.
Nativ O.: Experience with Synergo Treatment in NMIBC and Conservative Approach for High Risk Bladder Cancer. Meeting of the German Urological Association, Giessen, Germany, 2010.
Nativ O.: Current Treatment Options for Metastatic RCC: The Role of the Urologist. Israel Urological Association Meeting, Eilat, Israel, 2011.
Nativ O.: The Role of Endocrine Treatment in Localized Prostate Cancer. Israel Urological Association Meeting, Eilat, Israel, 2011.
Nativ O: Importance of Renal Function Preservation during Nephron Sparing Surgery. FOIU, Tel Aviv, Israel, 2012
Nativ O: Renal Surgery. International Robotic and Open Surgery Symposium, USC Institute of Urology, LA, USA, 2013.
Nativ O: Predicting Progression of Bladder Urothelial Carcinoma using microRNA Expression. WCC, Nanjing, China, 2014.